{"id":"https://openalex.org/W7224420454","doi":"https://doi.org/10.5281/zenodo.23759233","title":"NITROSAMINE DRUG SUBSTANCE-RELATED IMPURITIES: COMPARATIVE FDA AND EMA REGULATORY FRAMEWORKS, ANALYTICAL CHALLENGES, AND SUPPLY IMPLICATIONS","display_name":"NITROSAMINE DRUG SUBSTANCE-RELATED IMPURITIES: COMPARATIVE FDA AND EMA REGULATORY FRAMEWORKS, ANALYTICAL CHALLENGES, AND SUPPLY IMPLICATIONS","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224420454","doi":"https://doi.org/10.5281/zenodo.23759233"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23759233","doi":"https://doi.org/10.5281/zenodo.23759233","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23759233","pdf_url":null,"source":{"id":"https://openalex.org/S2764492878","display_name":"World Journal of Pharmaceutical Research","issn_l":"2277-7105","issn":["2277-7105"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.5281/zenodo.23759233","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160069707","display_name":"Purva Pawar1, Dhaval Desai2, Piyush Modi*3, Jigneshkumar Modasiya4","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Purva Pawar1, Dhaval Desai2, Piyush Modi*3, Jigneshkumar Modasiya4","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160069707"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8016948,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.3986999988555908,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.3986999988555908,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.3003000020980835,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.11259999871253967,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitrosamines","display_name":"nitrosamines","score":0.7459999918937683},{"id":"https://openalex.org/keywords/fda-regulatory-framework","display_name":"FDA regulatory framework","score":0.6899999976158142},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7649999856948853},{"id":"https://openalex.org/keywords/mutagenicity-testing","display_name":"mutagenicity testing","score":0.8059999942779541},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.847000002861023},{"id":"https://openalex.org/keywords/regulatory-harmonization","display_name":"regulatory harmonization","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pharmaceutical-supply-chain","display_name":"pharmaceutical supply chain","score":0.6069999933242798},{"id":"https://openalex.org/keywords/regulatory-submissions","display_name":"regulatory submissions","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.6315000057220459},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5230000019073486},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5084999799728394},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.4844000041484833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47850000858306885},{"id":"https://openalex.org/C61272859","wikidata":"https://www.wikidata.org/wiki/Q7834031","display_name":"Transferability","level":3,"score":0.47540000081062317},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.445499986410141},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4372999966144562},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.42100000381469727},{"id":"https://openalex.org/C3020792226","wikidata":"https://www.wikidata.org/wiki/Q1331083","display_name":"Human use","level":2,"score":0.3889000117778778},{"id":"https://openalex.org/C2778236407","wikidata":"https://www.wikidata.org/wiki/Q1041116","display_name":"Generally recognized as safe","level":2,"score":0.36480000615119934},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.36149999499320984},{"id":"https://openalex.org/C2993769243","wikidata":"https://www.wikidata.org/wiki/Q484652","display_name":"International agency","level":3,"score":0.3463999927043915},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.32030001282691956},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.30799999833106995},{"id":"https://openalex.org/C108713360","wikidata":"https://www.wikidata.org/wiki/Q1824206","display_name":"Supply chain","level":2,"score":0.296999990940094},{"id":"https://openalex.org/C177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.29429998993873596},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2906999886035919},{"id":"https://openalex.org/C194051981","wikidata":"https://www.wikidata.org/wiki/Q1337691","display_name":"Economic shortage","level":3,"score":0.2903999984264374},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.2881999909877777},{"id":"https://openalex.org/C114246631","wikidata":"https://www.wikidata.org/wiki/Q187661","display_name":"Carcinogen","level":2,"score":0.2802000045776367},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.2759000062942505},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.2736000120639801},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C2780511413","wikidata":"https://www.wikidata.org/wiki/Q18749628","display_name":"Regulatory affairs","level":2,"score":0.2621000111103058},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.25429999828338623},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.25209999084472656},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.25029999017715454},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23759233","doi":"https://doi.org/10.5281/zenodo.23759233","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23759233","pdf_url":null,"source":{"id":"https://openalex.org/S2764492878","display_name":"World Journal of Pharmaceutical Research","issn_l":"2277-7105","issn":["2277-7105"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23759234","doi":"https://doi.org/10.5281/zenodo.23759234","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23759234","pdf_url":null,"source":{"id":"https://openalex.org/S2764492878","display_name":"World Journal of Pharmaceutical Research","issn_l":"2277-7105","issn":["2277-7105"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23759233","doi":"https://doi.org/10.5281/zenodo.23759233","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23759233","pdf_url":null,"source":{"id":"https://openalex.org/S2764492878","display_name":"World Journal of Pharmaceutical Research","issn_l":"2277-7105","issn":["2277-7105"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393393898","https://openalex.org/W7214560365","https://openalex.org/W6930555508","https://openalex.org/W4406065160","https://openalex.org/W7170761819","https://openalex.org/W7204864229","https://openalex.org/W3183288223","https://openalex.org/W4408778906","https://openalex.org/W6911289275","https://openalex.org/W7216181274"],"abstract_inverted_index":{"Nitrosamine":[0],"drug":[1],"substance-related":[2],"impurities":[3],"(NDSRIs)":[4],"became":[5],"a":[6,151],"significant":[7],"global":[8,182],"concern":[9],"after":[10],"nitrosamines":[11],"were":[12],"found":[13],"in":[14,48],"angiotensin":[15],"receptor":[16],"blockers":[17],"and":[18,25,29,63,71,102,117,127,173,176,186],"other":[19],"medicines.":[20,191],"Both":[21],"the":[22,30,69,90,148,156],"US":[23],"Food":[24],"Drug":[26],"Administration":[27],"(FDA)":[28],"European":[31],"Medicines":[32],"Agency":[33],"(EMA)":[34],"aim":[35],"to":[36,40,189],"reduce":[37],"patient":[38,141],"exposure":[39],"these":[41],"potentially":[42],"harmful":[43],"impurities,":[44],"but":[45],"they":[46,53,82],"differ":[47],"their":[49,78,106],"legal":[50,79],"authority,":[51],"how":[52,68,81],"set":[54,83],"acceptable":[55],"intake":[56],"(AI)":[57],"limits,":[58,85],"implementation":[59],"timelines,":[60],"reporting":[61],"requirements,":[62],"flexibility.":[64],"This":[65],"review":[66,132],"examines":[67],"FDA":[70,135],"EMA":[72,149],"currently":[73],"manage":[74,103],"NDSRI":[75],"control,":[76],"covering":[77],"foundations,":[80],"AI":[84],"assess":[86],"structure-activity":[87],"relationships,":[88],"use":[89],"Carcinogenic":[91],"Potency":[92],"Categorization":[93],"Approach":[94],"(CPCA),":[95],"conduct":[96],"confirmatory":[97],"testing,":[98],"handle":[99],"regulatory":[100],"submissions,":[101],"products":[104],"throughout":[105],"lifecycle.":[107],"It":[108],"also":[109],"covers":[110],"analytical":[111,175],"method":[112],"development,":[113],"supply":[114],"chain":[115],"effects,":[116],"new":[118],"mutagenicity":[119],"testing":[120],"methods,":[121],"such":[122],"as":[123],"transgenic":[124],"rodent":[125],"assays":[126],"error-corrected":[128],"next-generation":[129],"sequencing.":[130],"The":[131],"finds":[133],"that":[134],"guidance":[136],"allows":[137],"product-specific":[138],"flexibility":[139],"when":[140],"access":[142,188],"is":[143],"at":[144],"risk.":[145],"In":[146],"contrast,":[147],"uses":[150],"more":[152,184],"formal":[153],"process":[154],"via":[155],"Committee":[157],"for":[158,161],"Medicinal":[159],"Products":[160],"Human":[162],"Use":[163],"(CHMP)":[164],"Article":[165],"5(3)":[166],"opinion.":[167],"Greater":[168],"harmonization,":[169],"better":[170],"compound-specific":[171],"data,":[172],"improved":[174],"toxicological":[177],"tools":[178],"could":[179],"help":[180],"make":[181],"standards":[183],"consistent":[185],"protect":[187],"important":[190]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-30T00:00:00"}